CLINICAL RESEARCH
Clinical implications of plasma Nogo-A levels in patients with coronary heart disease
,
 
,
 
,
 
,
 
 
 
More details
Hide details
 
Submission date: 2015-11-11
 
 
Final revision date: 2015-12-11
 
 
Acceptance date: 2015-12-28
 
 
Online publication date: 2016-03-23
 
 
Publication date: 2017-06-08
 
 
Arch Med Sci 2017;13(4):771-777
 
KEYWORDS
TOPICS
ABSTRACT
Introduction: Nogo-A is an important neurite growth-regulatory protein in the adult and developing nervous system. Recently, increasing evidence has shown that Nogo-A plays important roles in cardiac development and may act as a potential indicator for heart failure. In addition, increased oxidative stress has been found in individuals with cardiovascular diseases. However, not much is known regarding the expression levels of Nogo-A and reactive oxygen species (ROS) in patients with coronary heart disease (CHD). Therefore, we sought to investigate the relationship between Nogo-A, ROS levels and CHD.
Material and methods: The plasma Nogo-A and ROS concentrations of 122 acute coronary syndrome (ACS), 101 unstable angina pectoris (UAP), and 21 acute myocardial infarction (AMI) patients and 56 healthy controls were measured by enzyme-linked immunosorbent assay (ELISA). We further generated a receiver operating characteristic (ROC) curve to assess the diagnostic accuracy of Nogo-A and ROS in CHD.
Results: The Nogo-A and ROS levels were significantly higher in patients with CHD than those in healthy controls. In addition, multivariate logistic regression analysis revealed that the level of Nogo-A (odds ratio (OR) = 1.624, 95% confidence interval: 1.125–2.293, p = 0.009) is a risk factor for prediction of CHD. Nogo-A has diagnostic value, with an optimal threshold of 5.466 ng/ml for maximized diagnostic performance (59% sensitivity and 78.6% specificity, area under curve, p < 0.05). However, ROS concentration is not a risk factor for prediction of CHD (OR = 0.999, 95% confidence interval: 0.997–1.001, p = 0.320).
Conclusions: Increased plasma Nogo-A level may be associated with CHD.
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top